Eterna Therapeutics Inc (ERNA) Live Share Price, Invest From India

Eterna Therapeutics Inc Stock Performance

as on May 8, 2026 at 6:59 am IST

Day's Low
Day's High
$6.25
Day's Price Range
$8.49
$7.82
20.08%
Downside
8.57%
Upside
52 Week's Low
52 Week's High
$3.18
52-Week Price Range
$100.46
$7.82
59.30%
Downside
1184.69%
Upside

Eterna Therapeutics Inc share price movements today

Previous Close: $6.04
Open: $6.96
Volume: 9.2M
Day's Low - High: $6.25 - $8.49
52 Week Low - High: $3.18 - $100.46

Eterna Therapeutics Inc Historical Returns

1 Month Return: + 12.9 %
3 Month Return: -35.8 %
1 Year Return: -92.22 %
3 Year Return: -99.49 %
5 Year Return: 0 %

Eterna Therapeutics Inc Stock Fundamentals & Key Indicators

Check Eterna Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.0M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-9.3M

Revenue (TTM)

1.0K

Profit Margin

0.00%

Return On Equity TTM

-686.69%

Eterna Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eterna Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Eterna Therapeutics Inc	SELL	$7.0M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.5B	130.77%	76.32	12.55%
BeiGene, Ltd.	NA	$32.5B	NA	70.89	5.37%
Vertex Pharmaceuticals Inc	BUY	$108.5B	98.9%	25.38	35.51%
Regeneron Pharmaceuticals Inc	BUY	$75.6B	45.15%	17.6	29.65%

Stock Returns calculator for Eterna Therapeutics Inc Stock including INR - Dollar returns

The Eterna Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Eterna Therapeutics Inc investment value today

Current value as on today

₹11,207

Returns

-₹88,793

(-88.79%)

Returns from Eterna Therapeutics Inc Stock

-₹89,925 (-89.93%)

Dollar Impact

₹1,132 (+1.13%)

Analyst Recommendation on Eterna Therapeutics Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Eterna Therapeutics Inc. Average target price of $3

Eterna Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Eterna Therapeutics Inc.

What analysts predicted

-160.67%DOWNSIDE

Target Price

Current Price

$7.82

Analyzed by

6 Analysts

Target

$3.00

Eterna Therapeutics Inc target price $3, a slight downside of -160.67% compared to current price of $7.82. According to 6 analysts rating.

Indian Investors' Interest in Eterna Therapeutics Inc Stock

Search interest for Eterna Therapeutics Inc Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 8, 2026 to May 8, 2026

Change:-16% versus previous 30 day period

Eterna Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	0	0	0	0	0	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	-	0
Operating Income	-5	-5	-5	-4	-2	-2	-2	-2	-1	-2
EBITDA	-4	-5	-5	-4	-24	-2	-2	-2	-1	-2
Interest Expense	0	0	0	0	1	3	0	-	0	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-6	-6	-5	-26	-5	-8	-3	-1	-1
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-5	-6	-6	-5	-26	-5	-8	-3	-1	-1
Net Profit Margin	-10962.75%	-36194.12%	-14142.55%	-11763.83%	-5462.83%	-575900.00%	0.00%	0.00%	0.00%	0.00%

Eterna Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	22	21	23	19	5	-	-	0	0	-
Gross Profit	14	14	14	11	0	0	0	0	0	0
Operating Income	-2	-1	0	-1	-7	-113	-33	-21	-15	-9
EBITDA	0	0	3	1	-26	-121	-24	-19	-36	-9
Interest Expense	0	0	0	0	0	0	0	0	6	0
Depreciation	-	-	-	-	0	0	0	0	1	0
Income Before Tax	-2	-1	0	-2	-26	-122	-24	-21	-44	-14
Income Tax Expense	0	0	0	0	-19	0	0	0	0	0
Net Income	-2	-1	0	-2	11	-122	-24	-21	-44	-14
Net Profit Margin	-13.10%	-5.06%	-1.11%	-10.34%	205.28%	0.00%	0.00%	-31864.71%	-7652.75%	0.00%

Eterna Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-6	-6	-5	-26	-5	-8	-3	-1	-1
Operating Cash Flow	-4	-3	-2	-6	-3	-2	-2	-1	-1
Investing Cash Flow	0	0	0	0	-	-	-	0	0
Financing Cash Flow	7	1	0	3	1	2	4	0	-7
Change in Cash	3	-2	-2	1	-2	0	2	-1	-1

Eterna Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	0	-2	-26	-122	-24	-21	-44	-14
Operating Cash Flow	0	1	2	-8	-23	-20	-20	-15	-7
Investing Cash Flow	-1	-1	-1	0	-22	0	0	0	0
Financing Cash Flow	-1	0	-1	4	61	19	16	6	7
Change in Cash	-2	0	0	-1	15	-1	-3	-9	0

Global Institutional Holdings in Eterna Therapeutics Inc

Funds	Holdings
Genworth Financial Wealth Mgmt Inc	0%
CI Private Wealth LLC	1.62%
Activest Wealth Management	0%
Morgan Stanley - Brokerage Accounts	0%
Geode Capital Management, LLC	0.08%

See all

Insights on Eterna Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ERNA stock has moved up by 63.7%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.4% return, outperforming this stock by 124.9%
NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 34.9% return, outperforming this stock by 127.1%

About Eterna Therapeutics Inc

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Organisation	Eterna Therapeutics Inc
Headquarters	1035 Cambridge Street, Cambridge, MA, United States, 02141
Industry	Biotechnology
CEO	Mr. Sanjeev Luther
E-voting on shares	Click here to vote

Key Management of Eterna Therapeutics Inc

Name	Title
Ms. Sandra M. Gurrola	Senior VP of Finance
Dr. Robert Hamilton Pierce M.D.	Chief Scientific Officer
Ms. Dorothy J. Clarke	General Counsel
Dr. Kanika Chawla Ph.D.	Senior Vice President of Technical Operations (Consultant)
Mr. Sanjeev Luther	CEO, President & Director

FAQs

What is Eterna Therapeutics Inc share price today?

Eterna Therapeutics Inc share price today is $7.82 as on May 8, 2026 at 1:29 am IST at the close of the market. Eterna Therapeutics Inc share today touched a day high of $8.49 and a low of $6.25.

What is the 52 week high and 52 week low for Eterna Therapeutics Inc share?

Eterna Therapeutics Inc share touched a 52 week high of $100.46 on May 14, 2025 and a 52 week low of $3.18 on May 4, 2026. Eterna Therapeutics Inc stock price today i.e. May 8, 2026 at 1:29 am IST is closed at $7.82,which is 92.22% down from its 52 week high and 145.69% up from its 52 week low.

What is Eterna Therapeutics Inc's market capitalisation today?

Eterna Therapeutics Inc market capitalisation is $0.00T as on May 8, 2026 at 1:29 am IST.

How to invest in Eterna Therapeutics Inc Stock (ERNA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eterna Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eterna Therapeutics Inc Shares that will get you 0.1918 shares as per Eterna Therapeutics Inc share price of $7.82 per share as on May 8, 2026 at 1:29 am IST.

What is the minimum amount required to buy Eterna Therapeutics Inc Stock (ERNA) from India?

Indian investors can start investing in Eterna Therapeutics Inc (ERNA) shares with as little as ₹94.24 or $1 (as of May 8, 2026 at 1:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Eterna Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 8, 2026 at 1:39 am IST). Based on Eterna Therapeutics Inc share’s latest price of $7.82 as on May 8, 2026 at 1:29 am IST, you will get 1.2788 shares of Eterna Therapeutics Inc. Learn more about fractional shares .